MIT Technology Review @techreview
The @US_FDA has approved its second CAR-T cell therapy, which reprograms immune cells so they attack cancer. https://t.co/MQZUMluGVG — PolitiTweet.org
Created
Thu Oct 19 18:15:03 +0000 2017
Likes
45
Retweets
36
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely AvailableMIT Technology Review @techreview
The @US_FDA has approved its second CAR-T cell therapy, which reprograms immune cells so they attack cancer. https://t.co/MQZUMluGVG — PolitiTweet.org